首页> 美国卫生研究院文献>Molecules >Design Synthesis Antimicrobial and Anticancer Activities of Acridine Thiosemicarbazides Derivatives
【2h】

Design Synthesis Antimicrobial and Anticancer Activities of Acridine Thiosemicarbazides Derivatives

机译:cr啶硫代氨基脲衍生物的设计合成抗菌和抗癌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Acridine and thiourea derivatives are important compounds in medicinal chemistry due to their diverse biological properties including anticancer and antimicrobial effects. However, literature reveals some side effects associated with use of acridines. It is suggested that hybrid molecules may reduce the side effects and enhance the beneficial properties due to synergistic activity. The objectives of the present study are to synthesize and evaluate the anticancer and antimicrobial properties of new hybrids of acridine thiosemicarbazides derivatives. >Results: The structures of the synthesized compounds >4a–4e were elucidated by MS and NMR spectra. In antimicrobial assay, Compound >4c exhibited potent antimicrobial activity compared to the other four compounds. In anticancer studies, we observed that compounds >4a, >4b, >4d and >4e exhibited high cytotoxicity against the MT-4 cell line, with IC50 values of 18.42 ± 1.18, 15.73 ± 0.90, 10.96 ± 0.62 and 11.63 ± 0.11 μM, respectively. The evaluation of anticancer effects, and the associated mechanism reveals that, the anticancer activities may be related to Topo I inhibitory activity, apoptosis and cell-cycle. Molecular docking studies revealed that the presence of planar naphtho-fused rings and a flexible thiourea group together, could improve DNA-intercalation and inhibition of DNA-Topo I activity. >Conclusions: The results of this study demonstrate that the rational design of target derivatives as novel antimicrobial or antitumor leads is feasible.
机译:>背景: cr啶和硫脲衍生物由于其多种生物学特性(包括抗癌和抗菌作用),在药物化学中是重要的化合物。但是,文献揭示了一些与使用use啶有关的副作用。提示杂合分子可由于协同活性而减少副作用并增强有益特性。本研究的目的是合成和评估of啶硫代氨基脲衍生物的新杂化物的抗癌和抗菌性能。 >结果:合成的化合物> 4a-4e 的结构通过MS和NMR光谱进行了阐明。在抗菌测定中,与其他四种化合物相比,化合物> 4c 具有较强的抗菌活性。在抗癌研究中,我们观察到化合物> 4a ,> 4b ,> 4d 和> 4e 对MT-有较高的细胞毒性4个细胞系,IC50值分别为18.42±1.18、15.73±0.90、10.96±0.62和11.63±0.11μM。对抗癌作用及其相关机制的评估表明,抗癌活性可能与Topo I抑制活性,细胞凋亡和细胞周期有关。分子对接研究表明,平面萘稠合环和柔性硫脲基团的存在可以改善DNA嵌入和抑制DNA-Topo I活性。 >结论:该研究结果表明,合理设计目标衍生物作为新型抗微生物或抗肿瘤药物是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号